In 2020, HP+ reported results from a comparison of health and HIV financing trends and analysis of HIV funding prospects in 15 Asian countries that received Global Fund and/or PEPFAR financing support. The findings provided insight on (1) how much countries could increase spending on health and HIV and (2) the types of investments or changes to spending that were needed given the epidemiological and programmatic context. Given the deteriorating macroeconomic outlook and shifting health financing landscape due to the COVID-19 pandemic, the analysis has been updated to better understand the capacity of country governments to increase spending on HIV in the short term. The updated 2022 report takes into consideration the potential effects of COVID-19 on economic growth projections and prioritization of specific health areas. HP+ projects that overall government funding for health in 2022 may be 53 percent less than estimates projected prior to the pandemic, even under an optimistic scenario in which health budgets maintain a boost from COVID-19 spending going forward. The findings and key takeaways can inform Global Fund applications and grant negotiations.
Marra, K., C. Cantelmo, and P. Stegman. 2022. Effects of COVID-19 on HIV Financing Prospects in 15 Asian Countries. Washington, DC: Palladium, Health Policy Plus. USAID DEC: PA-00Z-6GJ
English PDF 1640.0 kbJanuary 2022
Cantelmo, C. and K. Ward. 2020. HIV Financing Landscape Analysis and Future Funding Prospects in 15 Asian Countries. Washington, DC: Palladium, Health Policy Plus. USAID DEC: PA-00W-PFH
English PDF 1028.6 kbJune 2020
Information presented on this website is considered public information and may be distributed or copied freely unless identified as being subject to copyright protection.